Females fend off gut diseases

A microscopic image shows an inflamed intestine in a male mouse. MSU professor Laura McCabe and colleagues found that something about female mice seems to protect them from inflammatory bowel diseases. Credit: Michigan State University

At least among mice, females have innate protection from certain digestive conditions, according to a new Michigan State University study.

While it's tricky to draw conclusions for human health, the findings could eventually help scientists better understand and treat the 1.4 million Americans suffering from inflammatory bowel diseases, or IBD.

Crohn's disease and colitis, the two most common forms of IBD, involve abnormal functioning of the immune system that can damage the digestive tract, causing inflammation, diarrhea, constipation, abdominal pain and other symptoms.

For the study, researchers induced colitis by giving mice with a dose of bacteria that can cause digestive trouble. After six weeks, the males had significantly more severe symptoms than the females and had more of the bacteria left in their guts. The males also showed more deterioration of their bones, which studies have linked to gut inflammation.

"It seems females are protected from bad bacteria-induced , and it's because they have reduced gut inflammation," said co-author Laura McCabe, a professor in the MSU Departments of Physiology and Radiology. "When we looked at markers of inflammation in the male mice, they were really high, whereas the females didn't have that kind of bad response. They can somehow handle these nasty bacteria."

McCabe said while the new study is a step toward better understanding of IBD, it's not clear if women have the same kind of resistance to the condition as the . Indeed, much is still unknown about IBD, including what causes it. The imbalance of good and bad that the experiment simulated is one possible cause.

"We want to know what it is about female mice allowing them to be protected," she said. "If we can understand that, we might have a potential for people with IBD."

The study was funded by the Crohn's and Colitis Foundation of America and appears in the journal Inflammatory Bowel Diseases.

Related Stories

Inflammatory bowel disease raises risk of melanoma

May 20, 2013

Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. ...

Study furthers understanding of IBD

Oct 12, 2012

Researchers part-funded by the Medical Research Council (MRC) and the Wellcome Trust have identified how particular parts of the intestinal immune system and the bacteria in the gut can interact to alter ...

Recommended for you

Phthalates heighten risk for childhood asthma

Sep 17, 2014

Researchers at the Columbia Center for Children's Environmental Health at the Mailman School of Public Health are the first to demonstrate an association between childhood asthma and prenatal exposure to two phthalates used ...

ERS: Mepolizumab is glucocorticoid-sparing in asthma

Sep 09, 2014

(HealthDay)—For patients with eosinophilic asthma, mepolizumab has a glucocorticoid-sparing effect and reduces exacerbations when administered intravenously or subcutaneously, according to two studies published ...

User comments